Lsv Asset Management Ani Pharmaceuticals Inc Transaction History

Lsv Asset Management

$46.7 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	SELL	$29.83 - $38.01 $856,121 - $1.09 Million	-28,700 Reduced 44.84%	35,300 $1.14 Million
Q2 2022 Aug 10, 2022	SELL	$23.09 - $33.46 $60,034 - $86,996	-2,600 Reduced 3.9%	64,000 $1.9 Million
Q1 2022 May 12, 2022	BUY	$26.91 - $47.15 $88,803 - $155,595	3,300 Added 5.21%	66,600 $1.87 Million
Q4 2021 Jan 28, 2022	SELL	$32.97 - $56.85 $837,438 - $1.44 Million	-25,400 Reduced 28.64%	63,300 $2.92 Million
Q2 2021 Aug 04, 2021	BUY	$31.86 - $38.6 $80,096 - $97,040	2,514 Added 2.92%	88,700 $3.11 Million
Q1 2021 Apr 30, 2021	BUY	$28.4 - $36.14 $593,162 - $754,820	20,886 Added 31.98%	86,186 $3.11 Million
Q4 2020 Feb 08, 2021	SELL	$23.69 - $31.47 $21,321 - $28,323	-900 Reduced 1.36%	65,300 $1.9 Million
Q3 2020 Oct 23, 2020	SELL	$26.38 - $33.1 $84,416 - $105,920	-3,200 Reduced 4.61%	66,200 $1.87 Million
Q2 2020 Aug 05, 2020	SELL	$29.93 - $50.1 $62,853 - $105,210	-2,100 Reduced 2.94%	69,400 $2.24 Million
Q1 2020 May 07, 2020	SELL	$30.35 - $67.14 $12,140 - $26,856	-400 Reduced 0.56%	71,500 $2.91 Million
Q4 2019 Feb 10, 2020	SELL	$55.65 - $79.83 $1.3 Million - $1.86 Million	-23,300 Reduced 24.47%	71,900 $4.43 Million
Q3 2019 Nov 07, 2019	SELL	$64.7 - $85.39 $1.22 Million - $1.61 Million	-18,800 Reduced 16.49%	95,200 $6.94 Million
Q2 2019 Aug 08, 2019	BUY	$67.77 - $82.2 $2.18 Million - $2.65 Million	32,215 Added 39.39%	114,000 $9.37 Million
Q1 2019 May 07, 2019	BUY	$45.83 - $70.54 $819,669 - $1.26 Million	17,885 Added 27.99%	81,785 $5.77 Million
Q4 2018 Feb 05, 2019	SELL	$41.17 - $56.44 $9.51 Million - $13 Million	-231,000 Reduced 78.33%	63,900 $2.88 Million
Q3 2018 Nov 06, 2018	SELL	$52.95 - $71.34 $291,225 - $392,370	-5,500 Reduced 1.83%	294,900 $16.7 Million
Q2 2018 Aug 08, 2018	SELL	$56.38 - $68.08 $304,452 - $367,632	-5,400 Reduced 1.77%	300,400 $20.1 Million
Q1 2018 May 04, 2018	BUY	$56.98 - $72.41 $16 Million - $20.3 Million	280,600 Added 1113.49%	305,800 $17.8 Million
Q4 2017 Feb 01, 2018	BUY	$53.3 - $74.56 $47,970 - $67,104	900 Added 3.7%	25,200 $0
Q3 2017 Nov 13, 2017	BUY	$43.46 - $52.49 $1.06 Million - $1.28 Million	24,300	24,300 $1.28 Million

Others Institutions Holding ANIP

# of Institutions

210

Shares Held

18.2M

Call Options Held

11.7K

Put Options Held

10.5K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.01B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Lsv Asset Management with notifications on news.

Account